regenerative medicine

The partnership combines the Artificial Intelligence (AI) capabilities of Wipro Holmes with Pandorum’s expertise in regenerative…

There are currently 53 marketed RM products and 175 RM pipeline agents in development in the eight major markets

New research from the University of Sheffield has suggested ways to reduce the likelihood of mutations occurring in these cells…

Targets the largely untapped biosimilars, regenerative medicine and diagnostic imaging agents space by increasing its IP assets

Application of stem cell-based therapies will be the turning point in the treatment of hitherto inadequately treated or incurable…